OXGENE’s novel mammalian antibody display technology targets challenging membrane proteins and facilitates downstream antibody manufacturing.
Antibody at the edge of impossible
Our proprietary mammalian antibody discovery platform and custom antibody libraries break new ground in the identification of novel antibodies against challenging membrane proteins. We also offer a bioinformatics-led approach to humanise existing antibodies, and our industry leading SnapFast™ plasmid technology facilitates subsequent antibody engineering and production steps.
We offer an integration solution that supports your entire antibody discovery, engineering and characterization workflow.